- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03715738
MEasurement by a Numerical Approach of BREAst Volume (MENABREA)
MEasurement by a Numerical Approach of BREAst Volume MENABREA
Breast asymmetry is a rare in plastic surgery. In majority of cases, it is idiopathic.
In cases that are poorly tolerated physically (vertebral imbalance, posture disorders) or psychologically, the decision to perform breast symmetrization surgery can be made. It is recommended to do this surgery after a slimming treatment if the woman is overweight or after pregnancy that causes a change in the structure and volume of the chest. In fact, the weight variations deteriorate the long-term result.
However, this surgical management remains difficult. In fact, the volume to be removed (unilateral breast reduction) to be symmetrized is a function of the volume of the contralateral breast and the preoperative drawings are made while standing. Currently, the evaluation of the volume to be removed remains subjective and is based on the experience of the surgeon. In addition, intraoperatively, this evaluation is also subjective because the patient is lying down which changes the position of the anatomical landmarks: the optimization of the symmetrization is only possible by the eye and the touch.
No measuring device is currently used to assess the difference in volume between the 2 breasts and guide the surgeon in the volume (or weight) to remove. It is therefore sometimes necessary to perform a second intervention in case of residual postoperative asymmetry.
Primary objective :
To study the association between the weight of tissues removed during the intervention and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland measured by electronic palpation (MyotonPRO).
Second objective : To study the association between the weight of tissues removed during the procedure and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland estimated by manual palpation (Likert scale from 1 to 5).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients referred for uni / bilateral breast reduction as part of an indication of surgical management.
- Major patients.
- Patients affiliated or beneficiaries of a social security scheme
- Patients who have signed prior informed consent.
Exclusion Criteria:
- Protected patients (pregnant, parturient and lactating women, persons deprived of their liberty by an administrative or judicial decision, persons undergoing psychiatric care under duress, minors, adults over the age of 18) legal protection measure or unable to express their consent).
- Patients unfit to understand the objectives or instructions of the study.
- Patients in an exclusion period relative to another interventional study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: arm 1 : Creaform3D + MyotonPRO
A clinical questionnaire is completed by the investigator (chest circumference, thorax turn, breast "measurements"). The breast density is assessed by the surgeon and scored from 1 to 5 (Likert scale) and then by the MyotonPRO The volumetric measurement of the breast is performed using the 3D digital camera. The patient is bent forward with hands resting on a chair during 30 seconds to 1 minute. The 3D digital camera rotates around the breast to capture the volume of the breast. Intraoperatively, the weight of tissues removed is weighed (in grams), recorded in the observation notebook. In post-operative (4 months), the possible long-term complications related to the intervention (mainly the dissatisfaction of the patient as for the aesthetic result) are collected then a new acquisition of the mammary volume is carried out with the digital camera 3D. Once this measurement is completed, participation in the study is complete |
After inclusion,are carried out:
The volumetric measurement of the breast is performed using the 3D digital camera. The patient is bent forward with hands resting on a chair to be as still as possible over a period of 30 seconds to 1 minute. The 3D digital camera rotates around the breast to capture the volume of the breast. In peroperative, the weight of tissues removed is weighed (in grams). The removed weight is recorded in the observation notebook. In postoperative (4 months), the possible long-term complications related to the intervention (mainly the dissatisfaction of the patient as for the aesthetic result) are collected then a new acquisition of the mammary volume is carried out with the digital camera 3D. Once this measurement is completed, participation in the study is complete. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
association between weight and volume adjusted to the density of the gland measured by electronic palpation
Time Frame: one year
|
To study the association between the weight of tissues removed during the intervention and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland measured by electronic palpation (MyotonPRO). Primary judgment criterion: Coefficient associated with volume variation in the linear regression model (model 1) explaining weight by volume variation and density measured by electronic palpation. |
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
association between weight and volume adjusted to the density of the gland estimated by manual palpation
Time Frame: one year
|
To study the association between the weight of tissues removed during the procedure and the variation of the breast volume (pre / postoperative) measured by the Créaform® GOPRO 3D digital camera adjusted on the density of the gland estimated by manual palpation (Likert scale from 1 to 5). Secondary judgment criterion 1: Coefficient associated with volume variation in the linear regression model (Model 2) explaining weight by volume variation and estimated density by manual palpation. |
one year
|
comparison of models 1 and 2
Time Frame: one year
|
Comparison of models 1 and 2 (estimated density by manual palpation or measured by electronic method), to see if one model is better than the other. Secondary judgment criterion 2: Akaike Criterion |
one year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2018-A02018-47
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Asymmetry, 3D
-
Orbix Medical Ltd.UnknownBreast Asymmetry Between Native Breast and Reconstructed BreastItaly
-
Lawson Health Research InstituteNot yet recruitingBreast Cancer | Gynecomastia | Transgenderism | Breast Asymmetry
-
Hacettepe UniversityCompletedUpper Limb AsymmetryTurkey
-
Lawson Health Research InstituteNot yet recruitingBreast Asymmetry | Fat Atrophy
-
Centre Oscar LambretCompletedBreast Cancer | 2D Mammography | 3D MammographyFrance
-
Ain Shams UniversityRecruiting
-
Centre hospitalier de l'Université de Montréal...Eiffel MedtechNot yet recruiting3D Knee KinematicsCanada
-
Carilion ClinicVirginia Polytechnic Institute and State UniversityNot yet recruitingOstomy | Leakage | 3D Printing
-
HaEmek Medical Center, IsraelTerminatedFetal Ventricle Brain Asymmetry
-
Weill Medical College of Cornell UniversityWithdrawn3D Transesophageal and Transthoracic EchocardiogramUnited States
Clinical Trials on arm 1 : Creaform3D + MyotonPRO
-
Jonsson Comprehensive Cancer CenterAmerican Cancer Society, Inc.Completed
-
VA Office of Research and DevelopmentCompletedSpinal Cord InjuriesUnited States
-
Hôpital NOVOCompletedHemiplegia and/or Hemiparesis Following StrokeFrance
-
Morehouse School of MedicineNational Cancer Institute (NCI)UnknownColorectal CancerUnited States
-
The University of Texas Health Science Center,...Brighter BitesActive, not recruiting
-
Children's Cancer Hospital Egypt 57357CompletedPediatric Brain Stem GliomaEgypt
-
Indiana UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes MellitusUnited States
-
MD Stem CellsEnrolling by invitationSpinal Cord Diseases | Spinal Cord Injuries | SCI - Spinal Cord Injury | Paraplegia | Spinal Cord Compression | Spinal Cord Ischemia | Paraplegia, Spinal | Paraplegia; Traumatic | Spinal Paralysis | Paraplegia/ParaparesisUnited States
-
Abbott NutritionCompleted
-
Boston Scientific CorporationCompletedSudden Cardiac DeathUnited States, Spain, Korea, Republic of, United Kingdom, Canada, Japan, Austria, Italy